$VRTX VERTEX PHARMACEUTICALS INC / MA Insider Trading Week 20/2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA in week 20/2020.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 288.37 | 9 | 2,595 | 26,626 | 26.6 K to 26.6 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 287.63 | 19 | 5,465 | 26,635 | 26.7 K to 26.6 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 286.07 | 27 | 7,724 | 26,654 | 26.7 K to 26.7 K (-0.10 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 283.76 | 10 | 2,838 | 26,681 | 26.7 K to 26.7 K (-0.04 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 282.74 | 4 | 1,131 | 26,691 | 26.7 K to 26.7 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 281.74 | 6 | 1,690 | 26,695 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 280.47 | 9 | 2,524 | 26,701 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 279.70 | 7 | 1,958 | 26,710 | 26.7 K to 26.7 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 276.40 | 6 | 1,658 | 26,717 | 26.7 K to 26.7 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Kewalramani Reshma | CEO & President | Sell | S | 274.37 | 2 | 549 | 26,723 | 26.7 K to 26.7 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 288.38 | 9 | 2,595 | 12,738 | 12.7 K to 12.7 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 287.61 | 33 | 9,491 | 12,747 | 12.8 K to 12.7 K (-0.26 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 286.12 | 20 | 5,722 | 12,780 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 284.30 | 10 | 2,843 | 12,800 | 12.8 K to 12.8 K (-0.08 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 281.23 | 21 | 5,906 | 12,810 | 12.8 K to 12.8 K (-0.16 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 279.93 | 17 | 4,759 | 12,831 | 12.8 K to 12.8 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Tatsis Ourania | EVP, Chief Regulato ... | Sell | S | 276.35 | 10 | 2,764 | 12,848 | 12.9 K to 12.8 K (-0.08 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 288.04 | 47 | 13,538 | 14,932 | 15 K to 14.9 K (-0.31 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 287.00 | 14 | 4,018 | 14,979 | 15 K to 15 K (-0.09 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 285.51 | 20 | 5,710 | 14,993 | 15 K to 15 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 282.85 | 10 | 2,829 | 15,013 | 15 K to 15 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 281.81 | 20 | 5,636 | 15,023 | 15 K to 15 K (-0.13 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 279.89 | 30 | 8,397 | 15,043 | 15.1 K to 15 K (-0.20 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Controller | Sell | S | 275.71 | 10 | 2,757 | 15,073 | 15.1 K to 15.1 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 288.23 | 9 | 2,594 | 26,838 | 26.8 K to 26.8 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 287.50 | 18 | 5,175 | 26,847 | 26.9 K to 26.8 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 286.27 | 9 | 2,576 | 26,865 | 26.9 K to 26.9 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 285.19 | 4 | 1,141 | 26,874 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 284.03 | 3 | 852 | 26,878 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 283.03 | 4 | 1,132 | 26,881 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 282.02 | 4 | 1,128 | 26,885 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 280.34 | 11 | 3,084 | 26,889 | 26.9 K to 26.9 K (-0.04 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 278.69 | 1 | 279 | 26,900 | 26.9 K to 26.9 K (0.00 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 276.46 | 2 | 553 | 26,901 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 275.54 | 2 | 551 | 26,903 | 26.9 K to 26.9 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 273.91 | 1 | 274 | 26,905 | 26.9 K to 26.9 K (0.00 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 288.35 | 9 | 2,595 | 35,179 | 35.2 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 287.62 | 24 | 6,903 | 35,188 | 35.2 K to 35.2 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 286.41 | 21 | 6,015 | 35,212 | 35.2 K to 35.2 K (-0.06 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 285.00 | 10 | 2,850 | 35,233 | 35.2 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 283.58 | 10 | 2,836 | 35,243 | 35.3 K to 35.2 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 280.71 | 12 | 3,369 | 35,253 | 35.3 K to 35.3 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 279.93 | 17 | 4,759 | 35,265 | 35.3 K to 35.3 K (-0.05 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 276.35 | 10 | 2,764 | 35,282 | 35.3 K to 35.3 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 288.05 | 19 | 5,473 | 28,902 | 28.9 K to 28.9 K (-0.07 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 287.19 | 15 | 4,308 | 28,921 | 28.9 K to 28.9 K (-0.05 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 286.12 | 10 | 2,861 | 28,936 | 28.9 K to 28.9 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 284.98 | 5 | 1,425 | 28,946 | 29 K to 28.9 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 283.74 | 3 | 851 | 28,951 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 282.77 | 6 | 1,697 | 28,954 | 29 K to 29 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 281.55 | 4 | 1,126 | 28,960 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 280.47 | 9 | 2,524 | 28,964 | 29 K to 29 K (-0.03 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 279.48 | 5 | 1,397 | 28,973 | 29 K to 29 K (-0.02 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 276.44 | 4 | 1,106 | 28,978 | 29 K to 29 K (-0.01 %) |
May 19 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 274.98 | 2 | 550 | 28,982 | 29 K to 29 K (-0.01 %) |